Beta-blockers provide a differential survival benefit in patients with coronary artery disease undergoing contemporary post-percutaneous coronary intervention management

Beta-adrenergic receptor blockers are used in patients with coronary artery disease (CAD) to reduce the harmful effects of excessive adrenergic activation on the heart. However, there is limited evidence regarding the benefit of beta-blockers in the context of contemporary management following percu...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Pil Hyung, Park, Gyung-Min, Han, Seungbong, Kim, Yong-Giun, Lee, Jong-Young, Roh, Jae-Hyung, Lee, Jae-Hwan, Kim, Young-Hak, Lee, Seung-Whan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7746699/
https://www.ncbi.nlm.nih.gov/pubmed/33335231
http://dx.doi.org/10.1038/s41598-020-79214-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7746699/
https://www.ncbi.nlm.nih.gov/pubmed/33335231
http://dx.doi.org/10.1038/s41598-020-79214-0

Ejemplares similares